Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort

Philip A. Beer, Peter J. Campbell, Linda M. Scott, Anthony J. Bench, Wendy N. Erber, David Bareford, Bridget S. Wilkins, John T. Reilly, Hans C. Hasselbalch, Richard Bowman, Keith Wheatley, Georgina Buck, Claire N. Harrison, Anthony R. Green

Blood (2008) 112 (1): 141–149.

https://doi.org/10.1182/blood-2008-01-131664

Published: 2008

Includes: Supplemental data

Journal Articles

Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation

Peter J. Campbell, E. Joanna Baxter, Philip A. Beer, Linda M. Scott, Anthony J. Bench, Brian J. P. Huntly, Wendy N. Erber, Rajko Kusec, Thomas Stauffer Larsen, Stéphane Giraudier, Marie-Caroline Le Bousse-Kerdilès, Martin Griesshammer, John T. Reilly, Betty Y. Cheung, Claire N. Harrison, Anthony R. Green

Blood (2006) 108 (10): 3548–3555.

https://doi.org/10.1182/blood-2005-12-013748

Published: 2006

Journal Articles

Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis

Steffen Klippel, Elisabeth Strunck, Snezana Temerinac, Anthony J. Bench, Gerold Meinhardt, Ursula Mohr, Rosi Leichtle, Anthony R. Green, Martin Griesshammer, Hermann Heimpel, Heike L. Pahl

Blood (2003) 102 (10): 3569–3574.

https://doi.org/10.1182/blood-2003-03-0919

Published: 2003

Journal Articles

Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability

Brian J. P. Huntly, Anthony J. Bench, Eric Delabesse, Alistair G. Reid, Juan Li, Mike A. Scott, Lynda Campbell, Jennie Byrne, Eleanor Pinto, Andre Brizard, Deitger Niedermeiser, Elizabeth P. Nacheva, Francois Guilhot, Michael Deininger, Anthony R. Green

Blood (2002) 99 (12): 4547–4553.

https://doi.org/10.1182/blood.V99.12.4547

Published: 2002

Journal Articles

Rescue of the lethal scl −/− phenotype by the human SCL locus

Angus M. Sinclair, Anthony J. Bench, Adrian J. C. Bloor, Juan Li, Berthold Göttgens, Maureen L. Stanley, Jane Miller, Sandie Piltz, Susie Hunter, Elisabeth P. Nacheva, Marı́a-José Sanchez, Anthony R. Green

Blood (2002) 99 (11): 3931–3938.

https://doi.org/10.1182/blood.V99.11.3931

Published: 2002

Journal Articles

Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia

Brian J. P. Huntly, Alistair G. Reid, Anthony J. Bench, Lynda J. Campbell, Nick Telford, Patricia Shepherd, Jeff Szer, H. Miles Prince, Paul Turner, Colin Grace, Elizabeth P. Nacheva, Anthony R. Green

Blood (2001) 98 (6): 1732–1738.

https://doi.org/10.1182/blood.V98.6.1732

Published: 2001

NARROW

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort

Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation

Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis

Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability

Rescue of the lethal scl −/− phenotype by the human SCL locus

Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia

Email alerts

ASH Publications

American Society of Hematology

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort

Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation

Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis

Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability

Rescue of the lethal scl −/− phenotype by the human SCL locus

Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only